Image

A Phase I Study of LXP1788 Injection with Advanced Solid Tumors.

Investigating the Safety and Tolerability of a Study Drug in Advanced Solid Tumors

Recruiting
18 years and older
All
Phase 1
  • Simplified description (AI rewritten)
  • Technical description (Original)

This study investigates the condition of advanced solid tumors. It focuses on understanding how the investigational medication works in people with this condition.

The purpose of this study is to evaluate the safety and tolerability of the investigational medication. It also looks at how the body processes the medication.

  • Who can participate: Adults aged 18 and older with advanced solid tumors that do not respond to existing treatments or have no available effective treatments can participate. Participants must have a life expectancy of more than 8 weeks and meet specific health criteria.
  • Study details: Participants will receive the investigational medication and have their health monitored.
Print
Study details
    Solid Tumor Malignancies
    Cancer
    Solid Cancers
    Solid Tumor Cancer
    Solid Tumor
    Unspecified
    Adult
    Solid Tumour
    Solid Tumors Refractory to Standard Therapy
    HCC - Hepatocellular Carcinoma
    RCC
    Renal Cell Cancer
    Pancreas Cancer

NCT06883539

LaunXP Biomedical Co., Ltd.

31 July 2026

Contact a study center
Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.